glp-1 news today september 29 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Legislators need to reinstate GLP-1

Bioinformatics 2019, 35 (22), 48624865

Noonan K

Research published in the National Library of Medicine shows that semaglutide-based treatments produced meaningful weight reductions in adults with obesity or weight-related conditions

While resistance exercises are particularly recommended to protect against the loss of bone density often associated with lower estrogen levels, HT also makes exercising easier, which helps maintain a healthy weight

Many of us have only ever worked from generic advice, without a personalised target that reflects the phase of life we're genuinely moving through

Recent research suggests that medications for type 2 diabetes of the GLP-1 class, such as Ozempic or Mounjaro, could offer an additional benefit beyond glycemic control: reduce the risk of dangerous blood clots in people with diabetes.This finding represents a new potential advantage for those who use these treatments